A New Risk Score Based on Lipid Indicators for Patients with Advanced Hepatocellular Carcinoma
- Xing Wei 1, Ziwei Guo 2, Tingting Zhang 3, Jun Liang 1
- Xing Wei 1, Ziwei Guo 2, Tingting Zhang 3
- 1Department of Medical Oncology, Peking University International Hospital, Beijing, People's Republic of China.
- 2Department of Medicine, Double Crane Runchuang Technology (Beijing) Co., Ltd, Beijing, People's Republic of China.
- 3Department of General Surgery, Beijing Friendship Hospital, Capital Medical University, State Key Laboratory of Digestive Health, National Clinical Research Center for Digestive Diseases, Beijing, People's Republic of China.
- 0Department of Medical Oncology, Peking University International Hospital, Beijing, People's Republic of China.
Related Experiment Videos
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.A new risk score using lipid markers improves prognosis prediction for advanced hepatocellular carcinoma (HCC). This score aids in assessing patient outcomes and durable clinical benefit more effectively than existing methods.
Area Of Science
- Hepatology
- Oncology
- Biochemistry
Background
- Advanced hepatocellular carcinoma (HCC) presents a challenging prognosis.
- Existing prognostic scores for HCC may lack sufficient positive predictive value.
- There is a need for efficient tools to assess prognosis and clinical response in HCC patients.
Purpose Of The Study
- To develop a novel, rapid, and effective risk score for advanced HCC.
- To evaluate the score's ability to predict prognosis and clinical response.
- To identify key prognostic variables in HCC.
Main Methods
- Retrospective analysis of 391 HCC patients (2015-2024), divided into training and validation cohorts.
- Utilized X-tile software for risk group stratification.
- Employed COX proportional risk model, Kaplan-Meier analysis, time-dependent ROC curves, and nomogram analysis.
Main Results
- Free fatty acid/high-density lipoprotein cholesterol (FFHL), tumor size, and BCLC stage were independent prognostic factors for overall survival (OS).
- The developed risk score demonstrated significant prognostic value (p < 0.001) in both groups.
- The score showed high predictive accuracy for progress-free survival (PFS) and OS, with AUCs ranging from 0.592 to 0.981.
- The score provided a more accurate evaluation of durable clinical benefit (DCB) compared to best overall response (BOR).
Conclusions
- A novel risk score incorporating lipid markers is a valuable tool for HCC prognosis.
- This score effectively distinguishes patients who will achieve durable clinical benefit.
- The developed score offers an improved method for assessing treatment response and patient outcomes in advanced HCC.
Related Experiment Videos
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
Related Concept Videos
01:25
Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
01:25
Endoscopic Ultrasound (EUS) and FibroScan are valuable diagnostic tools in gastroenterology and hepatology, each with specific applications and techniques.
Endoscopic Ultrasound (EUS):
Technological Integration: EUS is a sophisticated integration of optical endoscopy and ultrasonography. The endoscope visualizes the mucosal surface directly, while the ultrasound component penetrates deeper to visualize organs and structures beyond the gastrointestinal wall.
Image Formation: The ultrasound...

